FPW
GILD icon

Flagship Private Wealth’s Gilead Sciences GILD Stock Holding History

Flagship Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36
Closed -$2.48K – 144
2021
Q2 		$2.48K Hold
36
– – ﹤0.01% 307
2021
Q1 		$2.4K Hold
36
– – ﹤0.01% 279
2020
Q4 		$2.37K Buy
+36
New +$2.17K ﹤0.01% 293

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Flagship Private Wealth's GILD Position: Q3 2021 in Review

Flagship Private Wealth sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 36 shares — an estimated $2.48K sold.

Flagship Private Wealth first reported a position in GILD in Q4 2020 and held it in 3 quarters. The position peaked at $2.48K in Q2 2021. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Flagship Private Wealth reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
  • Flagship Private Wealth sold 36 Gilead Sciences shares in Q3 2021, an estimated $2.48K.
  • Flagship Private Wealth first reported a position in Gilead Sciences in Q4 2020 and held it in 3 quarters.
  • Flagship Private Wealth's Gilead Sciences position peaked at $2.48K in Q2 2021.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Flagship Private Wealth's 13F filing for Q3 2021, filed 20 Oct 2021.